Webinar Overview
Presenters
Marie-Laurence Baille
Senior Microbiology Specialist
MSD
Duncan Barlow
Scientific Portfolio Specialist
Charles River Laboratories
Lessons learned from feasibility for validation and implementation
Pharmaceutical manufacturers frequently face challenges of mold contamination in production facilities. To mitigate the risk of further environmental or product contamination, it is essential to identify mold as quickly and accurately as possible.
Marie-Laurence Baille from MSD (Merck in the US and Canada) shares her experience on how they approached mold identification difficulties at their global sites, internal challenges with LSU D2 sequencing, and limitations of infrequently updated libraries.
During her presentation, she shares:
- An overview of MALDI-TOF technology for fungal ID
- Feasibility study results for MALDI-TOF set-up
- How limitations of database and taxonomy can impact results
Following the case study, Duncan Barlow unpacks further fungal identification insights:
- The differences between the D2 and ITS2 regions for sequencing
- Why ITS2 has become the most widely sequenced DNA region for fungi in recent years
- How frequently Accugenix® updates and adds new fungal species and strains to the MALDI-TOF and ITS2 fungal libraries to improve ID rate
- The barriers Accugenix helps overcome to ensure difficult organisms such as fungi are accurately identified
Watch now and dive into key tactics to improve your fungal identification process and ID success rate. If you have any questions, email us at [email protected]